Click here to download the podcast.

In an exclusive interview, Modern Healthcare Washington reporter Rich Daly talks with Gordon Johnston, vice president of regulatory sciences at the Generic Pharmaceutical Association. He discusses some issues likely to impact the regulatory approval process being developed by the U.S. Food and Drug Administration for generic versions of biological medicines.

Read the accompanying Special Report "Similar concerns" published in the July 11, 2011, issue of Modern Healthcare.